CD8A and neoplasm: In contrast, the high-risk group had a diverse TIM with high concentrations of immune cells that promote tumor growth, such as Tregs and Th2, as well as immunological cells like natural killer (NK) cells and CD4/CD8 T cells, which halt tumor development.